Sign in
8-K

Current Report

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001193125-14-173024

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d720801d8k.htm…